Stock listing

Shanghai:603939 Yifeng Pharmacy Chain Co Ltd (益丰药房) 股价

Follow Yifeng Pharmacy Chain Co Ltd into a list and get an email when it puts out news.

Share price · SSE:603939

¥26.26 CNY -0.39 (-1.5%)

Close on Nov 20, 2026

Past year +10.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
¥26.02 – ¥26.85 CNYNov 20, 2026
Volume
12.87M sharesNov 20, 2026
Market cap
¥31.84B CNYAt the close on Nov 20, 2026 · price × 1.21B shares outstanding
52-week range
¥17.68 – ¥27.68 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
¥291.1M CNYMedian day 11.48M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Yifeng Pharmacy Chain Co Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SSE:603939 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥26.26-0.39-1.5%¥26.37¥26.85¥26.0212,869,876
¥26.65+0.04+0.2%¥26.48¥27.06¥26.2114,275,428
¥26.61+0.44+1.7%¥26.17¥26.65¥25.8513,889,996
¥26.17+0.69+2.7%¥25.48¥26.25¥25.3815,403,163
¥25.48+0.63+2.5%¥24.77¥25.72¥24.4015,952,340
¥24.85+0.33+1.3%¥24.50¥24.90¥23.8520,702,136
¥24.52-0.010.0%¥24.53¥24.74¥24.3410,705,989
¥24.53-0.79-3.1%¥25.20¥25.37¥24.4021,398,606
¥25.32-1.75-6.5%¥26.92¥27.07¥25.0229,066,856
¥27.07+0.39+1.5%¥26.20¥27.35¥26.1610,021,246
¥26.68-0.02-0.1%¥26.78¥26.95¥25.7515,726,399
¥26.70-0.64-2.3%¥27.34¥27.68¥26.4616,855,127
¥27.34+0.70+2.6%¥26.79¥27.50¥26.7014,935,106
¥26.64+0.18+0.7%¥26.54¥27.25¥26.2218,198,670
¥26.46+1.26+5.0%¥25.49¥26.84¥25.3818,707,513
¥25.20+0.29+1.2%¥25.00¥25.37¥24.767,246,455
¥24.91-0.66-2.6%¥25.32¥25.69¥24.8313,993,568
¥25.57+0.04+0.2%¥25.47¥25.90¥25.239,215,435
¥25.53+0.17+0.7%¥25.20¥25.93¥25.1011,397,873
¥25.36-0.29-1.1%¥25.70¥25.94¥25.2113,135,463
¥25.65+0.02+0.1%¥25.69¥25.80¥25.267,804,087
¥25.63-0.15-0.6%¥25.79¥26.10¥25.536,419,970
¥25.78+0.41+1.6%¥25.17¥25.94¥25.1713,147,171
¥25.37+0.29+1.2%¥24.94¥26.09¥24.7116,984,699
¥25.08-0.82-3.2%¥25.91¥26.19¥24.9015,534,479
¥25.90+0.47+1.8%¥25.43¥26.07¥25.0415,939,651
¥25.43+0.18+0.7%¥25.18¥25.88¥25.0213,498,948
¥25.25+0.26+1.0%¥25.02¥25.91¥24.6818,982,342
¥24.99+0.94+3.9%¥24.19¥25.30¥23.9518,956,635
¥24.05+0.52+2.2%¥23.59¥24.27¥23.4317,516,884
¥23.53+0.22+0.9%¥23.40¥23.75¥23.0312,504,346
¥23.31+0.30+1.3%¥23.40¥23.65¥22.8815,116,510
¥23.01+0.54+2.4%¥22.46¥23.04¥22.169,430,778
¥22.47+0.39+1.8%¥22.00¥22.48¥21.996,418,761
¥22.08-0.010.0%¥22.05¥22.33¥21.945,259,811
¥22.09-0.11-0.5%¥22.21¥22.34¥22.053,901,820
¥22.20+0.05+0.2%¥22.15¥22.59¥22.0611,553,711
¥22.15-0.63-2.8%¥22.76¥22.85¥22.138,167,610
¥22.78+0.03+0.1%¥22.69¥22.95¥22.556,337,213
¥22.75+0.14+0.6%¥22.57¥22.77¥22.373,898,066
¥22.61-0.06-0.3%¥22.68¥22.69¥22.325,242,924
¥22.67+0.010.0%¥22.66¥23.00¥22.603,938,800
¥22.66+0.18+0.8%¥22.46¥22.70¥22.385,270,552
¥22.48-0.19-0.8%¥22.77¥22.77¥22.239,902,668
¥22.67-0.14-0.6%¥22.80¥22.93¥22.505,111,918
¥22.81+0.17+0.8%¥22.55¥22.97¥22.455,454,068
¥22.64-0.18-0.8%¥22.82¥22.95¥22.2110,429,804
¥22.82-0.08-0.3%¥22.90¥23.35¥22.807,393,062
¥22.90+0.010.0%¥22.95¥23.08¥22.779,202,368
¥22.89+0.22+1.0%¥22.67¥23.06¥22.5112,592,951
¥22.67-0.27-1.2%¥23.00¥23.06¥22.5012,371,790
¥22.94+0.06+0.3%¥22.88¥23.05¥22.648,660,068
¥22.880.000.0%¥23.00¥23.17¥22.609,645,574
¥22.88-0.11-0.5%¥22.90¥23.30¥22.2014,502,548
¥22.99-0.72-3.0%¥23.67¥23.86¥22.9818,120,152
¥23.71-0.09-0.4%¥23.80¥24.03¥23.506,596,825
¥23.80+0.15+0.6%¥23.71¥23.97¥23.497,859,005
¥23.65-0.28-1.2%¥23.86¥24.10¥23.4010,592,160
¥23.93-0.20-0.8%¥24.13¥24.15¥23.726,439,170
¥24.13+0.16+0.7%¥24.16¥24.80¥24.007,553,687

Splits

4 splits since 2015 · SSE:603939 · every price before a split is adjusted for it

DayRatioWhat
7-for-5Split
13-for-10Split
7-for-5Split
2-for-1Split
Ticker
Shanghai:603939
Asset type
Stock
Sector
Retail & consumer services
Industry
Retail & e-commerce
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

All Yifeng Pharmacy Chain Co Ltd news

Yifeng Pharmacy Chain Co Ltd on 6ix

Sector
Retail & consumer services
Industry
Retail & e-commerce
News releases
58 in the last 12 months · 74 in all · newest Nov 20, 2026 · oldest 2025

Valuation

P/E 17.5× against a median of 14.8×: 7th lowest of 10 Retail & e-commerce companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
¥23.97B CNY
P/E
17.5×
EV/sales
0.9×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
2.6×
Gross margin
38.9%
Operating margin
10.9%
Net margin
7.1%
Debt to equity
0.1×
Beta
No index for this market yet

Retail & e-commerce: the 10 companies nearest in size, of 506 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Yifeng Pharmacy Chain Co Ltd Class A · SSE:603939US$4.78BUS$3.60B17.5×0.9×n/a2.6×7.1%0.1×n/a
Frasers Group PLC · LSE:FRASUS$5.16BUS$7.96B10.5×1.2×8.4×1.6×7.1%1.0×n/a
BBB Foods Inc. · NYSE:TBBBUS$5.06BUS$5.57Bn/a1.1×34.7×14.7×−2.0%2.6×0.58
Vipshop Holdings Ltd · NYSE:VIPSUS$4.99BUS$1.79B3.2×0.1×n/a0.7×9.8%0.3×0.45
Colruyt Group N.V. · EURONEXT:COLRUS$4.90BUS$5.09B14.7×0.4×5.3×1.4×2.9%0.3×n/a
Floor & Decor Holdings, Inc. · NYSE:FNDUS$4.89BUS$4.69B20.4×1.0×n/a2.0×5.1%0.1×1.39
CP Axtra Public Company Limited · SET:CPAXTUS$4.64BUS$6.95B16.8×0.5×6.9×0.5×1.8%0.3×n/a
Cencosud S.A. · BCS:CENCOSUDUS$4.57BUS$8.21B14.8×0.5×n/a0.9×1.9%0.9×n/a
B&M European Value Retail PLC · LSE:BMEUS$4.53BUS$7.20B21.1×0.9×8.2×4.2×2.8%3.0×n/a
Empire Co Ltd Class A · TSX:EMP.AUS$4.52BUS$9.72B29.6×0.4×5.7×1.3×0.7%1.5×0.02
Sprouts Farmers Market, Inc. · NASDAQ:SFMUS$4.50BUS$4.27B9.1×0.5×5.1×2.9×5.5%0.0×-0.01
Median of the othersUS$4.76BUS$6.26B14.8×0.5×6.9×1.5×2.9%0.6×0.45

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
32.24 CNY · Analysts' mean
EPS, year to Dec 2026
1.59 · 2 analysts
Revenue, year to Dec 2026
26.05B · 15 analysts

Events

QuarterResultsShare move
Q2 2026Aug 27, 2026 · After close−0.5%
Q1 2026Apr 22, 2026 · After close+5.5%
Q2 2025Aug 28, 2025 · Before open+1.5%
Q1 2025Apr 28, 2025 · Before open+2.6%
Q3 2024Oct 30, 2024 · After close+3.3%
Q2 2024Aug 29, 2024 · Before open+4.3%
Q1 2024Apr 28, 2024 · After close−0.7%
Q4 2023Jan 31, 2024 · After close+1.8%
Q3 2023Oct 30, 2023 · Before open+0.5%
Q2 2023Aug 29, 2023 · After close+0.3%
All 17 quarters
QuarterResultsShare move
Q1 2023Apr 27, 2023 · After close−3.7%
Q3 2022Oct 28, 2022 · Before open−1.7%
Q2 2022Aug 29, 2022 · Before open+0.2%
Q1 2022Apr 28, 2022 · After close+10.0%
Quarter to Sep 30, 2021Oct 29, 2021 · After close+4.2%
Quarter to Jun 30, 2021Aug 26, 2021 · After close−5.6%
Quarter to Mar 31, 2021Apr 29, 2021 · After close+1.1%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue24.4B24.1B22.6B19.9B15.3B13.1B10.3B6.91B4.81B3.73B
Cost of revenue14.8B14.5B14.0B12.1B9.18B8.18B6.28B4.18B2.89B2.26B
Gross profit9.62B9.57B8.56B7.80B6.14B4.96B3.99B2.73B1.92B1.47B
Research and development27.9M33.9M33.5M25.3M15.6M8.31M5.37M3.24M2.43M14.8M
Selling, general and administrative1.32B1.08B962.4M904.1M657.3M546.5M438.6M267.7M199.4M152.7M
Operating income2.51B2.20B2.05B1.89B1.34B1.13B815.5M578.3M427.2M296.2M
Depreciation and amortization1.75B1.88B1.83B1.44B1.19B111.4M94.7M70.3M50.1M37.8M
EBITDA4.26B4.09B3.89B3.33B2.53B1.24B910.2M648.6M477.3M333.9M
Interest expense166.8M246.6M160.5M178.0M169.0M200.0M60.6M23.0M15.9M9.86M
Income before tax2.46B2.18B2.04B1.88B1.34B1.13B814.3M581.3M428.1M305.8M
Income tax529.7M456.7M454.1M347.2M287.9M205.4M139.7M110.6M77.9M
Net income1.68B1.53B1.41B1.26B887.9M743.5M543.8M416.4M313.5M223.9M
Earnings per share, basic1.381.241.171.250.890.770.570.450.340.26

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.08B3.58B3.57B4.11B2.92B3.36B1.42B1.30B787.5M346.6M
Short-term investments5.85B4.41B1.63B50.0M152.2M744.8M193.2M292.8M937.9M1.48B
Receivables1.96B2.63B2.60B2.53B1.09B1.04B949.8M783.4M340.4M358.4M
Inventory4.64B4.53B3.81B3.61B3.04B2.17B1.82B1.44B764.2M730.1M
Current assets16.8B15.9B12.1B10.6B7.92B8.06B4.99B4.24B3.36B3.13B
Property, plant and equipment4.89B4.50B3.55B528.0M416.6M315.2M302.8M
Goodwill4.77B4.77B4.61B4.19B3.72B3.34B3.04B2.73B694.1M529.2M
Total assets27.5B28.0B24.1B21.0B17.1B12.9B9.18B7.87B4.78B4.22B
Accounts payable8.83B9.49B1.96B6.76B4.81B3.82B3.02B2.20B1.24B990.5M
Current liabilities11.8B12.6B11.3B9.66B6.75B5.14B3.73B2.90B1.56B1.20B
Long-term debt1.65B1.60B133.6M228.7M365.6M1.98B687.2M744.8M
Total debt3.94B2.34B3.46B3.33B2.42B775.4M789.0M920.2M745.0M
Total liabilities15.1B16.6B13.7B11.9B9.19B7.17B4.47B3.70B1.60B1.25B
Shareholders' equity11.6B10.7B9.80B8.56B7.48B5.47B4.51B4.06B3.17B2.96B
Shares outstanding1.21B1.23B1.21B1.01B1.00B967.4M960.8M927.5M924.5M860.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations3.36B4.22B4.66B3.92B2.15B1.34B963.2M510.7M317.2M139.9M
Capital spending-322.9M-682.7M-739.9M-587.5M-827.5M-582.8M-454.0M-233.7M-206.7M-254.9M
Free cash flow3.04B3.54B3.88B3.33B1.32B752.9M509.2M277.0M110.5M-114.9M
Cash from investing-3.61B-3.01B-1.27B-566.8M-1.26B-885.7M-482.3M-149.0M-1.54B
Cash from financing-920.2M-2.10B-1.66B-2.19B1.71B-125.4M526.4M-54.1M1.34B
Dividends paid-849.3M-846.5M-288.7M-215.6M-165.9M-113.7M-113.0M-183.6M-54.1M-54.1M
Share buybacks-4.00M-3.52M-2.85M-1.69M-2.22M-58.3M
Change in cash-547.5M-307.8M-449.6M991.0M-601.9M1.79B-47.8M554.9M114.1M-56.5M

Open Financials

Filings

FilingDateTypeFiled with
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionNov 20, 2026Operations updateShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Use of Idle Raised Funds for Cash ManagementNov 12, 2026Operations updateShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on the 2026 "Corporate Value and Return Enhancement" 2.0 Action PlanNov 10, 2026GuidanceShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Resolutions of the 37th Meeting of the 5th Board of DirectorsNov 10, 2026Meeting outcomeShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Adjustment of Matters Related to the 2026 Restricted Share Incentive PlanNov 10, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Initial Grant of Restricted Shares to Participants under the 2026 Restricted Share Incentive PlanNov 10, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Use of Idle Raised Funds for Cash ManagementNov 5, 2026Operations updateShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionNov 3, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Report for Q3 2026Oct 30, 2026Quarterly reportShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Key Operating Data for Q3 2026Oct 30, 2026ResultsShanghai Stock Exchange
All 74 filings
FilingDateTypeFiled with
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Resolutions of the 36th Meeting of the 5th Board of DirectorsOct 30, 2026Meeting outcomeShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Change in Accounting Policies and Correction of Non-recurring Gains and LossesOct 30, 2026ResultsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Oct 21, 2026Meeting outcomeShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionOct 16, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Self-inspection Report on Trading in the Company's Shares by Insiders in Relation to the 2026 Restricted Share Incentive PlanOct 14, 2026Legal or regulatory actionShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Review Opinion and Statement on the Public Disclosure of the List of Participants under the 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of DirectorsOct 13, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share ChangesOct 10, 2026FinancingShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionOct 10, 2026Operations updateShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash ManagementOct 10, 2026Operations updateShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Summary of 2026 Restricted Share Incentive Plan (Draft)Sep 30, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Appointment of Senior ExecutiveSep 30, 2026Other filingsShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026Sep 30, 2026Meeting noticeShanghai Stock Exchange
(603939)"Yifeng Pharmacy Chain Co., Ltd."Announcement on Resolutions of the 35th Meeting of the 5th Board of DirectorsSep 30, 2026Meeting outcomeShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Second Interim Trustee Management Report of CITIC Securities Company Limited for 2026 on the Issuance of Convertible Corporate Bonds to Unspecified Investors by Yifeng Pharmacy Chain Co., Ltd.Sep 29, 2026Other filingsShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 22, 2026DividendShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance BriefingSep 21, 2026Meeting noticeShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Not Revising Downward the Conversion Price of "Yifeng Convertible Bonds"Sep 16, 2026FinancingShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Indicative Announcement on "Yifeng Convertible Bonds" Expected to Trigger Downward Revision Condition of Conversion PriceSep 9, 2026FinancingShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026Aug 27, 2026DividendShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Return of Raised Funds Temporarily Used to Supplement Working CapitalAug 25, 2026Other filingsShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress of Initial Repurchase of Shares through Call AuctionAug 6, 2026Other filingsShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Repurchasing Shares through Call AuctionAug 3, 2026Other filingsShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share RepurchaseJul 30, 2026Other filingsShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Resolutions of the 32nd Meeting of the 5th Board of DirectorsJul 24, 2026Meeting outcomeShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash ManagementJul 20, 2026Operations updateShanghai Stock Exchange
"Yifeng Pharmacy Chain Co., Ltd."Announcement on Conversion Result of Convertible Bonds and Share ChangesJul 2, 2026FinancingShanghai Stock Exchange
Announcement on Follow-up Rating Results of Convertible Corporate BondsJun 22, 2026Other filingsShanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2025Jun 15, 2026DividendShanghai Stock Exchange
Indicative Announcement on Stopping the Conversion of "Yifeng Convertible Bonds" during Implementation of Dividend Distribution for 2025Jun 9, 2026DividendShanghai Stock Exchange
Announcement on Progress in Using Idle Raised Funds for Cash ManagementJun 3, 2026Operations updateShanghai Stock Exchange
Announcement on Not Revising Downward the Conversion Price of "Yifeng Convertible Bonds"May 26, 2026FinancingShanghai Stock Exchange
Announcement on Resolutions of the 2025 Annual General MeetingMay 22, 2026Meeting outcomeShanghai Stock Exchange
Indicative Announcement on Expected Triggering Conditions for Downward Correction of Conversion Price of "Yifeng Convertible Bonds"May 19, 2026FinancingShanghai Stock Exchange
Announcement on Performance Briefing for 2025 and Q1 2026May 15, 2026Meeting noticeShanghai Stock Exchange
Announcement on Redemption at Maturity of Idle Raised Funds Used for Cash ManagementMay 14, 2026FinancingShanghai Stock Exchange
Announcement on Resignation of Senior Management MemberMay 10, 2026Management or board changeShanghai Stock Exchange
Meeting Minutes of Investor Relations Activities (20260422)Apr 24, 2026Other filingsShanghai Stock Exchange
Announcement on 2025 Annual Profit Distribution PlanApr 22, 2026DividendShanghai Stock Exchange
Announcement on Opening Special Account for Temporary Supplementary Current of Raised Funds and Signing a Tripartite Supervision AgreementApr 17, 2026FinancingShanghai Stock Exchange
Announcement on Using Partial Idle Raised Funds for Cash ManagementApr 15, 2026Other filingsShanghai Stock Exchange
Announcement on Using Idle Raised Funds for Cash ManagementApr 2, 2026FinancingShanghai Stock Exchange
Announcement on Appointment of Senior Management MembersMar 27, 2026Management or board changeShanghai Stock Exchange
Announcement on Resignation of Senior Management MembersMar 6, 2026Management or board changeShanghai Stock Exchange
Announcement on Interest Payment for Corporate Convertible BondsFeb 24, 2026FinancingShanghai Stock Exchange
Announcement on Progress in Providing Guarantee for Holding SubsidiaryJan 7, 2026Other filingsShanghai Stock Exchange
Announcement on Conversion Result of Convertible Bonds and Share ChangesJan 5, 2026FinancingShanghai Stock Exchange
Announcement on Progress in Raised Funds for Entrusted Wealth ManagementDec 25, 2025Operations updateShanghai Stock Exchange
Announcement on Convening the Q3 2025 Performance BriefingNov 24, 2025Other filingsShanghai Stock Exchange
Announcement on Shareholding Reduction Plan of Senior Management MembersNov 16, 2025Other filingsShanghai Stock Exchange
Report for Q3 2025Oct 29, 2025Other filingsShanghai Stock Exchange
Announcement on 2nd Lifting of Restrictions of Reserved Shares under the 2022 Restricted Stock Incentive Plan and Listing of SharesOct 21, 2025Operations updateShanghai Stock Exchange
Announcement on Resolutions of the 22nd Meeting of the 5th Board of DirectorsSep 30, 2025Meeting outcomeShanghai Stock Exchange
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 22, 2025Meeting noticeShanghai Stock Exchange
Report of CITIC Securities Company Limited on the 2nd Temporary Entrusted Management Affairs of Convertible Corporate Bonds Issued by Yifeng Pharmacy Chain Co., Ltd. to Non-specific Objects in 2025Sep 16, 2025Other filingsShanghai Stock Exchange
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance BriefingSep 12, 2025Other filingsShanghai Stock Exchange
Announcement on Implementation of Semi-annual Dividend Distribution for 2025Sep 9, 2025DividendShanghai Stock Exchange
Indicative Announcement on Stopping the Conversion of "Yifeng Convertible Bonds" during Implementation of Semi-annual Dividend Distribution for 2025Sep 3, 2025DividendShanghai Stock Exchange
Announcement on Returning the Raised Funds of Convertible Corporate Bonds Temporarily Used to Supplement Current CapitalSep 2, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 21st Meeting of the 5th Board of DirectorsAug 28, 2025Other filingsShanghai Stock Exchange
Announcement on Election of Employee DirectorAug 25, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 20th Meeting of the 5th Board of DirectorsAug 14, 2025Other filingsShanghai Stock Exchange
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%Aug 6, 2025Other filingsShanghai Stock Exchange
Announcement on Postponing Some Investment Projects Financed by Raised FundsJul 30, 2025Other filingsShanghai Stock Exchange
Announcement on Redemption of Idle Raised Funds Used for Entrusted Wealth Management upon Maturity and Continuation of Entrusted Wealth ManagementJul 25, 2025Other filingsShanghai Stock Exchange

Open Filings

Cap table

Built by 6ix from Yifeng Pharmacy Chain Co Ltd Class A’s releases · as of Sep 30, 2026

Common shares
1,212,392,486
Fully diluted
1,212,392,486

Fully diluted

LineSharesAs of
Common shares1,212,392,486Sep 30, 2026

Share count over time

CountShares
Sep 30, 20261,212,392,486

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund1.1MUS$3.69MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund1.06MUS$3.56MJul 31, 2026
Mercer Emerging Markets Equity Fund1.04MUS$2.77MJun 30, 2026
Strategic Advisers Fidelity Emerging Markets Fund597KUS$1.86MMay 31, 2026
Siit Emerging Markets Equity Fund566KUS$1.77MMay 31, 2026
abrdn Emerging Markets Dividend Active ETF259KUS$871KJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund185KUS$622KJul 31, 2026
Strategic Advisers Emerging Markets Fund152KUS$474KMay 31, 2026
WisdomTree Emerging Markets SmallCap Dividend Fund123KUS$327KJun 30, 2026
Schwab Emerging Markets Equity ETF115KUS$359KMay 31, 2026
All 36 holders
HolderSharesValueAs of
State Street(R) SPDR(R) Portfolio Emerging Markets ETF104KUS$275KJun 30, 2026
Emerging Markets Core Equity 2 Portfolio71,351US$240KJul 31, 2026
PineBridge Dynamic Asset Allocation Fund67,400US$227KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF63,052US$212KJul 31, 2026
Vanguard Total World Stock Index Fund60,933US$205KJul 31, 2026
Dimensional Emerging Core Equity Market ETF50,859US$171KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF47,476US$160KJul 31, 2026
The Emerging Markets Series44,680US$150KJul 31, 2026
State Street(R) SPDR(R) S&P(R) China ETF25,456US$67,428Jun 30, 2026
Dimensional Emerging Markets Value Fund24,800US$83,524Jul 31, 2026
Dimensional Emerging Markets Value ETF18,600US$62,602Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF18,524US$49,066Jun 30, 2026
World ex U.S. Core Equity Portfolio14,396US$48,484Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio13,941US$46,952Jul 31, 2026
Vanguard ESG International Stock ETF13,900US$43,413May 31, 2026
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF13,176US$41,172May 29, 2026
Franklin FTSE China ETF12,200US$32,315Jun 30, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF10,944US$36,834Jul 31, 2026
Baillie Gifford China Equities Fund5,680US$15,074Jun 30, 2026
JPMorgan BetaBuilders Emerging Markets Equity ETF5,600US$18,851Jul 31, 2026
Putnam PanAgora ESG Emerging Markets Equity ETF3,098US$10,521Apr 30, 2026
Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF2,485US$7,769May 29, 2026
abrdn EM SMA Completion Fund1,600US$5,390Jul 31, 2026
BNY Mellon Emerging Markets Equity ETF1,220US$4,110Jul 31, 2026
JNL Emerging Markets Index Fund948US$2,516Jun 30, 2026
Franklin FTSE Asia ex Japan ETF316US$837Jun 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Yifeng Pharmacy Chain Co Ltd.